Dr. Xiaoquan Huang | Health and Medicine Advances | Research Excellence Award
Associate Researcher | Zhongshan Hospital, Fudan University | China
Dr. Xiaoquan Huang is an accomplished clinical researcher whose work centers on gastroenterology, hepatology, metabolic liver disease, portal hypertension, gastrointestinal bleeding, and global disease epidemiology. With 848 Scopus citations, 79 publications, and an h-index of 13, his research demonstrates sustained impact across Health Sciences, Pharmacology & Toxicology, Cardiology, Endocrinology, Geriatrics, Neurology, Psychiatry, Pulmonary Medicine, Radiology, and related clinical domains. His research portfolio features high-quality journal publications in Chinese Medical Journal, Journal of Gastroenterology and Hepatology, Thrombosis and Haemostasis, Endoscopy, Liver International, Therapeutic Advances in Chronic Disease, and Journal of Translational Medicine. His works span clinical investigations, systematic reviews, global burden analyses, and translational studies addressing cirrhosis-related complications, portal vein thrombosis, metabolic-associated fatty liver disease, and early-onset colorectal cancer. Dr. Xiaoquan Huang has also served as a corresponding author on several influential global epidemiology studies focused on colorectal cancer and fatty liver disease burden. Dr. Xiaoquan Huang’s scholarly contributions include research on variceal bleeding management, endoscopic innovations, thrombosis prediction markers, myeloproliferative neoplasm-associated portal hypertension, and gastrointestinal microbiome trends. His findings have advanced evidence-based approaches for cirrhotic complications, individualized treatment strategies, endoscopic therapy optimization, and risk stratification in liver disease. He has contributed to meta-analyses and systematic reviews, including work on transoral incisionless fundoplication (TIF) for GERD and therapeutic evaluations in portal hypertension, expanding global clinical understanding and practice guidelines. His research awards include multiple Young Investigator accolades from APDW, EASL, and JGHF, reflecting international recognition for innovation and research excellence. Dr. Xiaoquan Huang’s academic leadership includes reviewer service, conference presentations, and contributions to collaborative global research projects. His ongoing work continues to shape diagnostic, therapeutic, and epidemiological frameworks in hepatology and gastroenterology, establishing him as a significant contributor to clinical research and patient-centered innovations.
Featured Publications
1. Huang, X., Zou, D., Wang, H., Chen, W., Zhang, L., Li, F., Ma, L., Zhang, C., Chen, Y., & Chen, S. (2024). Gastric variceal obstruction improves the efficacy of endoscopic management of esophageal variceal bleeding in GOV type I. Endoscopy International Open, 12(8), E940–E946.
2. Wang, Y., Huang, X. (Corresponding author), Cheryala, M., Aloysius, M., Zheng, B., Yang, K., Chen, B., Fang, Q., Chowdary, S. B., Abougergi, M. S., & Chen, S. (2023). Global increase of colorectal cancer in young adults over the last 30 years: An analysis of the Global Burden of Disease Study 2019. Journal of Gastroenterology and Hepatology, 38(9), 1552–1558.
3. Jiang, S., Ai, Y., Fan, X., Huang, X. (Corresponding author), Wu, L., Ni, L., Li, F., & Chen, S. (2023). Increased factor VIII activity is predictive of the occurrence of portal vein thrombosis in cirrhosis. Thrombosis and Haemostasis, 123(7), 714–722.
4. Huang, X., Zhang, M., Ai, Y., Jiang, S., Xiao, M., Wang, L., Jian, Y., Zhuge, Y., Zhang, C., & Chen, S. (2022). Characteristics of myeloproliferative neoplasm-associated portal hypertension and endoscopic management of variceal bleeding. Therapeutic Advances in Chronic Disease, 13, Article 20406223221125691.
5. Huang, X., Abougergi, M. S., Sun, C., Murphy, D., Sondhi, V., Chen, B., Zheng, X., Chen, S., & Wang, Y. (2023). Incidence and outcomes of thromboembolic and bleeding events in patients with liver cirrhosis in the USA. Liver International, 43(2), 434–441.